Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: The REDHY study

Journal of Human Hypertension

Volumn 24, Issue 1, 2010, Pages 44-50

  Cerasola, G ^a   Mule G ^a   Nardi, E ^a   Cusimano, P ^a   Palermo, A ^a   Arsena, R ^a   Guarneri, M ^a   Geraci, C ^a   Cottone, S ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Albuminuria; Arterial hypertension; Estimated glomerular filtration rate; Renal dysfunction

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77449113991     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.41     Document Type: Article

References (34)

1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
2. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Seventh Report of The Joint National Committee, Evaluation and treatment of high blood pressure. JAMA 2003; 157: 2413-2446.
3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL et al. American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 2003; 42: 1050-1065.
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
5. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218-225.
6. Rahman M, Brown CD, Coresh J, Davis BR, Eckfeldt JH, Kopyt N, et al., Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease. Arch Intern Med 2004; 164: 969-976.
7. de Leeuw PW, Ruilope LM, Palmer CR, Brown MJ, Castaigne A, Mancia G et al. Clinical significance of renal function in hypertensive patients at high risk. Results from the INSIGHT trial. Arch Intern Med 2004; 164: 2459-2464.
8. Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P et al. VALUE Investigators. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J Hypertens 2007; 25: 1473-1479.
9. Cerasola G, Mulè G, Cottone S, Nardi E, Cusimano P. Hypertension, microalbuminuria and renal dysfunction. The REDHY (REnal Dysfunction in HYpertension) study. J Nephrol 2008; 21: 368-373.
10. Rose BD. Clinical assessment of renal function. In: Rose BD (ed). Pathophysiology of Renal Disease, 2nd edn. McGraw-Hill: New York (USA), 1987, pp 1-23.
11. Levey AS, Greene T, Kusek J, Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
12. Cerasola G, Cottone S, Mulè G, Nardi E, Mangano MT, Andronico G et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 1996; 14: 915-920.
13. Pedrinelli R, Dell’Omo G, Di Bello V, Pontremoli R, Mariani M. Microalbuminuria an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 2002; 16: 79-89.
14. Cerasola G, Cottone S. Microalbuminuria as a marker of vascular damage in hypertension: influence of blood pressure and metabolic pattern. Nutr Metab Cardiovasc Dis 1997; 7: 92-95.
15. Liese AD, Hense H-W, Doring A, Stieber J, Keil U. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens 2001; 15: 799-804.
16. Bonnet F, Marre M, Halimi JM, Stengel B, Lange C, Laville M, et al., DESIR Study Group. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 2006; 24: 1157-1163.
17. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
18. Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S et al. Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 2008; 23: 1265-1273.
19. Bakris L, Ritz E, on behalf of the World Kidney Day Steering Committee. The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented. J Hum Hypertens 2009; 23: 222-225.
20. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876.
21. Hsu C, Iribarren C, Go A. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 701-702.
22. Hailpern SM, Cohen HW, Alderman MH. Renal dysfunction and ischemic heart disease mortality in a hypertensive population. J Hypertens 2005; 23: 1809-1816.
23. Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 2008; 52: 39-48.
24. Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int 2000; 57: 1688-1703.
25. Carvalho KT, Silva MI, Bregman R. Nutritional profile of patients with chronic renal failure. J Ren Nutr 2004; 14: 97-100.
26. Leoncini G, Ratto E, Viazzi F, Conti N, Falqui V, Parodi A et al. Global risk stratification in primary hypertension: the role of the kidney. J Hypertens 2008; 26: 427-432.
27. Farbom P, Wahlstrand B, Almgren P, Skrtic S, Lanke J, Weiss L et al. Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study. Hypertension 2008; 52: 115-122.
28. Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, Vasan RS et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 2007; 167: 1386-1392.
29. Cirillo M, Lanti MP, Menotti A, Laurenzi M, Mancini M, Zanchetti A et al. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate. Arch Intern Med 2008; 168: 617-624.
30. Astor BC, Hallan SI, Miller ER, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008; 167: 1226-1234.
31. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483.
32. Cirillo M, Anastasio P, De Santo NG. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant 2005; 20: 1791-1798.
33. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
34. Mulè G, Cottone S, Vadalà A, Volpe V, Mezzatesta G, Mongioví R et al. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med 2004; 256: 22-29.